Recent medical research suggests that the gut microbiome plays a pivotal role in how the body responds to modern oncology treatments, particularly immunotherapies like checkpoint inhibitors. Because antibiotics are designed to eliminate bacteria, they can inadvertently strip the gut of the “good” microbes necessary to prime the immune system, potentially dampening the body’s ability to fight cancer cells effectively. At Royal Care Hospital Mirpur, we advocate for a balanced, “Value-Based” approach to medication, ensuring that antibiotics are prescribed with precision to avoid compromising the efficacy of ongoing cancer therapies.